These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta-analysis. Furukawa TA; Shinohara K; Sahker E; Karyotaki E; Miguel C; Ciharova M; Bockting CLH; Breedvelt JJF; Tajika A; Imai H; Ostinelli EG; Sakata M; Toyomoto R; Kishimoto S; Ito M; Furukawa Y; Cipriani A; Hollon SD; Cuijpers P World Psychiatry; 2021 Oct; 20(3):387-396. PubMed ID: 34505365 [TBL] [Abstract][Full Text] [Related]
3. Withdrawal effects confounding in clinical trials: another sign of a needed paradigm shift in psychopharmacology research. Cohen D; Recalt A Ther Adv Psychopharmacol; 2020; 10():2045125320964097. PubMed ID: 33224467 [TBL] [Abstract][Full Text] [Related]
4. Evidence-Based Applications of Combination Psychotherapy and Pharmacotherapy for Depression. Dunlop BW Focus (Am Psychiatr Publ); 2016 Apr; 14(2):156-173. PubMed ID: 31975799 [TBL] [Abstract][Full Text] [Related]
5. Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial. DeRubeis RJ; Zajecka J; Shelton RC; Amsterdam JD; Fawcett J; Xu C; Young PR; Gallop R; Hollon SD JAMA Psychiatry; 2020 Mar; 77(3):237-245. PubMed ID: 31799993 [TBL] [Abstract][Full Text] [Related]
6. Follow-up of monotherapy remitters in the PReDICT study: Maintenance treatment outcomes and clinical predictors of recurrence. Kennedy JC; Dunlop BW; Craighead LW; Nemeroff CB; Mayberg HS; Craighead WE J Consult Clin Psychol; 2018 Feb; 86(2):189-199. PubMed ID: 29369664 [TBL] [Abstract][Full Text] [Related]
7. Do Acute Benefits of Interpersonal Psychotherapy for Posttraumatic Stress Disorder Endure? Markowitz JC; Choo TH; Neria Y Can J Psychiatry; 2018 Jan; 63(1):37-43. PubMed ID: 28743198 [TBL] [Abstract][Full Text] [Related]
8. Physical activity in depressed elderly. A systematic review. Mura G; Carta MG Clin Pract Epidemiol Ment Health; 2013; 9():125-35. PubMed ID: 24009640 [TBL] [Abstract][Full Text] [Related]
9. Dysfunctional attitudes as a moderator of pharmacotherapy and psychotherapy for chronic depression. Shankman SA; Campbell ML; Klein DN; Leon AC; Arnow BA; Manber R; Keller MB; Markowitz JC; Rothbaum BO; Thase ME; Kocsis JH J Psychiatr Res; 2013 Jan; 47(1):113-21. PubMed ID: 23102821 [TBL] [Abstract][Full Text] [Related]
10. Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Freedland KE; Mohr DC; Davidson KW; Schwartz JE Psychosom Med; 2011 May; 73(4):323-35. PubMed ID: 21536837 [TBL] [Abstract][Full Text] [Related]
11. A review of empirically supported psychological therapies for mood disorders in adults. Hollon SD; Ponniah K Depress Anxiety; 2010 Oct; 27(10):891-932. PubMed ID: 20830696 [TBL] [Abstract][Full Text] [Related]
12. Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators. Driessen E; Hollon SD Psychiatr Clin North Am; 2010 Sep; 33(3):537-55. PubMed ID: 20599132 [TBL] [Abstract][Full Text] [Related]
13. Can pharmacotherapists be too supportive? A process study of active medication and placebo in the treatment of depression. Strunk DR; Stewart MO; Hollon SD; DeRubeis RJ; Fawcett J; Amsterdam JD; Shelton RC Psychol Med; 2010 Aug; 40(8):1379-87. PubMed ID: 19891806 [TBL] [Abstract][Full Text] [Related]
14. Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials. Rutherford BR; Sneed JR; Roose SP Psychother Psychosom; 2009; 78(3):172-81. PubMed ID: 19321970 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. Dobson KS; Hollon SD; Dimidjian S; Schmaling KB; Kohlenberg RJ; Gallop RJ; Rizvi SL; Gollan JK; Dunner DL; Jacobson NS J Consult Clin Psychol; 2008 Jun; 76(3):468-77. PubMed ID: 18540740 [TBL] [Abstract][Full Text] [Related]
16. Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. Fournier JC; DeRubeis RJ; Shelton RC; Gallop R; Amsterdam JD; Hollon SD Br J Psychiatry; 2008 Feb; 192(2):124-9. PubMed ID: 18245030 [TBL] [Abstract][Full Text] [Related]
17. Can pill placebo augment cognitive-behavior therapy for panic disorder? Furukawa TA; Watanabe N; Omori IM; Churchill R BMC Psychiatry; 2007 Dec; 7():73. PubMed ID: 18093337 [TBL] [Abstract][Full Text] [Related]
18. Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues. Blumenthal JA; Sherwood A; Rogers SD; Babyak MA; Doraiswamy PM; Watkins L; Hoffman BM; O'Connell C; Johnson JJ; Patidar SM; Waugh R; Hinderliter A Clin Trials; 2007; 4(5):548-59. PubMed ID: 17942470 [TBL] [Abstract][Full Text] [Related]
19. Exercise and pharmacotherapy in the treatment of major depressive disorder. Blumenthal JA; Babyak MA; Doraiswamy PM; Watkins L; Hoffman BM; Barbour KA; Herman S; Craighead WE; Brosse AL; Waugh R; Hinderliter A; Sherwood A Psychosom Med; 2007; 69(7):587-96. PubMed ID: 17846259 [TBL] [Abstract][Full Text] [Related]